Xylazine and Fentanyl in New York: The New Face of the Overdose Crisis

Naloxone (Narcan) reverses the opioid component of overdoses but does not act against adulterants like xylazine or medetomidine.

By Dr. Alberto Augsten, Toxicologist and Psychopharmacologist

The overdose crisis in New York has evolved. It is no longer only about fentanyl: a new generation of adulterants — led by xylazine ("tranq") and, more recently, medetomidine — is reshaping the clinical landscape and pushing emergency services, hospitals, and addiction-treatment programs across the state to their limits.

What Is Xylazine?

Xylazine is a veterinary sedative and alpha-2 adrenergic agonist that is NOT an opioid. That means naloxone (Narcan) does not reverse its sedative effects. When mixed with fentanyl — increasingly the case in the illicit drug supply — it prolongs sedation, deepens respiratory depression, and produces severe necrotic skin wounds that may require surgical debridement or even amputation.

Recent research from Columbia University's Social Intervention Group has documented near-universal fentanyl exposure among people who use drugs, with xylazine detected in roughly half of participants across several cities. In New York, xylazine prevalence continues to rise.

The Emerging Threat: Medetomidine

In April 2026, the CDC issued a national alert (HAN00527) on medetomidine — another alpha-2 veterinary sedative, more potent than xylazine — now detected in the illicit fentanyl supply. Its arrival increases overdose risk and produces a severe withdrawal syndrome marked by refractory hypertension, tachycardia, and agitation that can require intensive care.

What Every New York Family Should Know

Always carry naloxone: even though it doesn't reverse xylazine or medetomidine, it does reverse the opioid component (fentanyl) that is almost always present and is what kills.

Call 911 immediately: prolonged sedation from non-opioid adulterants requires advanced medical care.

Don't use alone: use the "Never Use Alone" hotline and the Overdose Prevention Centers (OPCs) operated by OnPoint NYC in East Harlem and Washington Heights.

Check wounds: non-healing ulcers on arms or legs in people who use drugs can be a sign of xylazine exposure and require urgent evaluation.

Drug-checking: fentanyl and xylazine test strips are available through harm-reduction programs of the NY State Department of Health.

The Clinical Toxicology Perspective

This is a polydrug crisis, not a single-agent crisis. The response must be equally multifaceted: widespread naloxone distribution, access to buprenorphine and methadone treatment, syringe service programs, housing, and wound care. Stigma kills; information saves lives.

If you or someone you know is at risk, call the New York HOPE line at 1-877-846-7369 or the Poison Control Center at 1-800-222-1222.